The purpose of this trial is to study fluorodeoxyglucose-positron emission tomography (FDG-PET)-based dose escalation using intensity modulated radiation therapy (IMRT).
The dose escalation, based on the FDG-PET signal, is incorporated in the first ten fractions of the radiotherapeutic treatment. The total amount of fractions is 32, equal to a standard radiotherapeutic treatment for these types of cancers.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
FDG-PET-based dose escalation using intensity modulated radiation therapy (IMRT).
University Hospital Ghent
Ghent, Belgium
Acute toxicity during radiotherapy until 3 months after the end of the radiotherapy
Time frame: until 3 months after the end of the radiotherapy
Observation of chronic toxicity
Time frame: until 3 months after the end of the radiotherapy
Therapy response (2-4 months after end of radiotherapy)
Time frame: 2-4 months after end of radiotherapy
Local control at 2 years
Time frame: at 2 years
Pattern of recurrence
Time frame: at 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.